Westlake Chemical PRN AI Stock Analysis
Want to see WLKP full AI Analyst Report?
Westlake Chemical PRN (WLKP) AI Stock Analysis
Westlake Chemical PRN
(NYSE:WLKP)
WLKP scores well primarily on strong profitability and especially strong free-cash-flow generation, reinforced by a positive earnings call that emphasized stable distributions, improved coverage, and no planned turnarounds. Valuation is supportive with a moderate P/E and high yield. The score is tempered by balance-sheet metric inconsistency and the history of earnings/cash-flow variability, while technicals are mildly positive rather than decisively strong.
Westlake Chemical PRN (WLKP) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $752.66M
- Dividend Yield
- 8.83%
- Average Volume (3M)
- 22.46K
- Price to Earnings (P/E)
- 12.6
- Beta (1Y)
- 0.16
- Revenue Growth
- 9.40%
- EPS Growth
- 20.34%
- Country
- US
- Employees
- 2,169
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
Westlake Chemical PRN Business Overview & Revenue Model
Company Description
Westlake Chemical Partners LP concentrates on acquiring, developing, and operating facilities dedicated to ethylene production, along with related infrastructure, throughout the United States. These plants primarily function by converting ethane into...
How the Company Makes Money
WLKP makes money primarily by producing ethylene and selling it under long-term contractual arrangements. Its key revenue stream is the sale of ethylene (and certain related coproducts, where applicable) generated from its owned production facilities...
Westlake Chemical PRN Earnings Call Summary
The call was strongly positive, with higher net income and distributable cash flow, improved coverage, a 49-quarter record of uninterrupted distributions, conservative leverage, strong liquidity, and no planned turnarounds. The primary challenge mentioned was volatility in third-party ethylene prices related to the ongoing conflict in the Middle East.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For modeling purposes, Westlake Partners has no planned turnarounds for the remainder of 2026 or in 2027. In the fourth quarter of 2026, third-party ethylene prices are currently higher than the average price in the third quarter of 2026, which could provide a modest benefit on the roughly 5% of annual sales made to third parties. The current Ethylene Sales Agreement is in place through 2027, discussions will occur next year, the $0.10 margin is considered an appropriate level right now, and Westlake Partners does not intend to change anything while it will try to negotiate higher prices. The Partnership expects to sustain its current distribution without the need to access the capital markets and will evaluate opportunities via its four levers of growth in the future.
Westlake Chemical PRN Financial Statement Overview
Summary
Strong operating profitability and cash generation: ~31% gross margin, ~29% EBIT margin, ~40% EBITDA margin, and robust TTM operating cash flow (~$483M) and free cash flow (~$456M) with healthy cash conversion (~0.88x of net income). Offsetting this, net margins are modest (~4–6%) and earnings/cash-flow trends have shown volatility; balance-sheet leverage metrics are also inconsistent (TTM debt figures vs higher reported debt-to-equity), adding uncertainty.
Income Statement
78PositiveBalance Sheet
60NeutralCash Flow
86Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.24B | 1.17B | 1.14B | 1.19B | 1.59B | 1.21B |
| Gross Profit | 389.27M | 347.85M | 418.94M | 387.46M | 377.37M | 441.71M |
| EBITDA | 495.14M | 450.00M | 507.59M | 472.14M | 470.33M | 519.56M |
| Net Income | 59.16M | 48.70M | 62.39M | 54.28M | 64.17M | 82.55M |
Balance Sheet | ||||||
| Total Assets | 1.23B | 1.26B | 1.29B | 1.32B | 1.37B | 1.48B |
| Cash, Cash Equivalents and Short-Term Investments | 47.65M | 44.27M | 58.32M | 58.62M | 64.78M | 17.06M |
| Total Debt | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M |
| Total Liabilities | 454.92M | 454.18M | 458.64M | 460.59M | 468.27M | 508.00M |
| Stockholders Equity | 253.47M | 501.11M | 518.70M | 522.51M | 534.50M | 536.55M |
Cash Flow | ||||||
| Free Cash Flow | 444.03M | 201.65M | 436.03M | 405.18M | 409.62M | 327.27M |
| Operating Cash Flow | 482.58M | 280.47M | 485.00M | 452.00M | 463.74M | 408.44M |
| Investing Cash Flow | -90.55M | 31.18M | -88.97M | -75.94M | -12.00M | -64.30M |
| Financing Cash Flow | -382.32M | -325.70M | -396.33M | -382.23M | -404.01M | -344.24M |
Westlake Chemical PRN Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For WLKP, the sentiment is Positive. The current price of 21.35 is above the 20-day moving average (MA) of 20.88, above the 50-day MA of 20.86, and above the 200-day MA of 21.06, indicating a bullish trend. The MACD of 0.10 indicates Negative momentum. The RSI at 60.37 is Neutral, neither overbought nor oversold. The STOCH value of 35.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for WLKP.
Westlake Chemical PRN Risk Analysis
Westlake Chemical PRN disclosed 2 risk factors in its most recent earnings report. Westlake Chemical PRN reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksWestlake Chemical PRN Peers Comparison
Overall Rating
WLKP79Outperform
SSL71Outperform
DOW60Neutral
OLN55Neutral
HUN49Neutral
BAK41Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 79Outperform | $752.66M | 12.62 | 15.70% | 8.83% | 9.40% | 20.34% | |
| 71Outperform | $8.42B | 11.85 | 7.73% | ― | 17.90% | 95.98% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 60Neutral | $22.71B | -24.96 | -4.50% | 4.46% | 4.16% | 20.86% | |
| 55Neutral | $1.91B | -11.36 | -9.57% | 4.78% | -0.73% | -415.18% | |
| 49Neutral | $1.61B | -9.63 | -6.12% | 3.81% | 6.49% | 47.81% | |
| 41Neutral | $422.36M | -0.48 | 46.16% | ― | -1.40% | 2.39% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| WLKP | Westlake Chemical Partners LP | 21.35 | 4.91 | 29.90% | |
| BAK | Braskem Sa | 0.89 | -2.15 | -70.72% | |
| HUN | Huntsman | 9.19 | 1.03 | 12.62% | |
| OLN | Olin Corporation | 16.72 | -1.44 | -7.93% | |
| SSL | Sasol Ltd | 12.95 | 5.65 | 77.40% | |
| DOW | Dow Inc. | 31.37 | 11.06 | 54.48% |
Westlake Chemical PRN Corporate Events
Westlake Chemical Partners Reports Third-Quarter Earnings and Distribution
PositiveWestlake Chemical Partners LP is a Houston-headquartered limited partnership focused on operating, acquiring and developing ethylene production facilities and other qualified assets. It owns a 22.8% interest in Westlake Chemical OpCo LP, whose assets...
Westlake Chemical Partners Reshapes Senior Financial Leadership Team
PositiveOn August 31, 2026, Westlake Chemical Partners LP announced that Tommy E. Darby was appointed Vice President and Chief Accounting Officer of Westlake Chemical Partners GP LLC, and concurrently of Westlake Corporation, bringing extensive experience fr...
Westlake Chemical Partners Extends Credit Facilities, Maintains Distributions
PositiveWestlake Chemical Partners LP reported net income attributable to the Partnership of $14.2 million, or $0.40 per limited partner unit, for the second quarter of 2026, slightly below the $14.6 million earned a year earlier. However, cash flows from op...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 04, 2026
